Reply to Benefit-harm ratio of the diagnostic workup in patients with prostate cancer and a Gleason score of 9 to 10. Kim DW, Tilki D, D'Amico AV. Cancer 2021 Jul 23. doi: 10.1002/cncr.33813.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim DW, Tilki D, D'Amico AV. Reply to Benefit-harm ratio of the diagnostic workup in patients with prostate cancer and a Gleason score of 9 to 10. Cancer 2021 Jul 23. doi: 10.1002/cncr.33813.
PMID: 34297845